Abbott Laboratories
ABT
£98.15
Share price
-0.25%
Change (1 day)
22.90%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Abbott Laboratories (ABT) - Total assets
Total assets on the balance sheet as of March 2025 : £59.94 Billion
According to Abbott Laboratories's latest financial reports the company's total assets are £59.94 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Abbott Laboratories - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | £64.87 B | 12.89% |
| 2023-12-31 | £57.46 B | -6.6% |
| 2022-12-31 | £61.52 B | 10.45% |
| 2021-12-31 | £55.70 B | 4.67% |
| 2020-12-31 | £53.22 B | 2.81% |
| 2019-12-31 | £51.77 B | -2.17% |
| 2018-12-31 | £52.91 B | -6.2% |
| 2017-12-31 | £56.41 B | 32.18% |
| 2016-12-31 | £42.68 B | 53.35% |
| 2015-12-31 | £27.83 B | 5.16% |
| 2014-12-31 | £26.46 B | 1.64% |
| 2013-12-31 | £26.03 B | -37.4% |
| 2012-12-31 | £41.59 B | 7.26% |
| 2011-12-31 | £38.78 B | -1.17% |
| 2010-12-31 | £39.23 B | 21.14% |
| 2009-12-31 | £32.39 B | 11.92% |
| 2008-12-31 | £28.94 B | 44.78% |
| 2007-12-31 | £19.99 B | 8.23% |
| 2006-12-31 | £18.47 B | 9.3% |
| 2005-12-31 | £16.89 B | 12.77% |
| 2004-12-31 | £14.98 B | 2.94% |
| 2003-12-31 | £14.55 B | -3.79% |
| 2002-12-31 | £15.12 B | -5.84% |
| 2001-12-31 | £16.06 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | £142.53 B | 137.78% | 🇺🇸 USA |
 Pfizer PFE | £153.10 B | 155.41% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | £72.89 B | 21.60% | 🇺🇸 USA |
 Hologic HOLX | £6.28 B | -89.51% | 🇺🇸 USA |
 Medtronic MDT | £67.47 B | 12.56% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | £68.02 B | 13.48% | 🇺🇸 USA |
 Boston Scientific BSX | £29.54 B | -50.72% | 🇺🇸 USA |
 AstraZeneca AZN | £78.19 B | 30.46% | 🇬🇧 UK |
 Novartis NVS | £73.55 B | 22.71% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | £57.72 B | -3.70% | 🇬🇧 UK |